Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:08 PM UTC
| NCT Number | NCT06807359 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 43 participants |
| Active Locations | 1 sites in the US |
| Sponsor | SpectraCure AB |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 16, 2026: Clinical trial NCT06807359 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by SpectraCure AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06807359 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06807359 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.